145 related articles for article (PubMed ID: 20358436)
21. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
22. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials.
Sethuraman V; Sun Q
Pharm Stat; 2009; 8(2):113-24. PubMed ID: 18481273
[TBL] [Abstract][Full Text] [Related]
23. Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.
Schall R; Ring A
Pharm Stat; 2011; 10(3):265-76. PubMed ID: 21574242
[TBL] [Abstract][Full Text] [Related]
24. Statistical issues of QT prolongation assessment based on linear concentration modeling.
Tsong Y; Shen M; Zhong J; Zhang J
J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
[TBL] [Abstract][Full Text] [Related]
25. Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.
Sun GG; Quan H
J Biopharm Stat; 2010 May; 20(3):683-7; author reply 688. PubMed ID: 20358445
[No Abstract] [Full Text] [Related]
26. An efficient and robust analysis of covariance model for baseline adjustment in parallel-group thorough QT/QTc studies.
Lu K
Stat Med; 2013 Jun; 32(14):2406-18. PubMed ID: 22996035
[TBL] [Abstract][Full Text] [Related]
27. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
28. Comparison of six commonly used QT correction models and their parameter estimation methods.
Wang D; Taubel J; Arezina R
J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
[TBL] [Abstract][Full Text] [Related]
29. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
Ogungbenro K; Aarons L
J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
[TBL] [Abstract][Full Text] [Related]
30. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
31. Testing for positive control activity in a thorough QTc study.
Zhang J
J Biopharm Stat; 2008; 18(3):517-28. PubMed ID: 18470760
[TBL] [Abstract][Full Text] [Related]
32. QT analysis: a complex answer to a 'simple' problem.
Li L; Desai M; Desta Z; Flockhart D
Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
[TBL] [Abstract][Full Text] [Related]
33. Guest editors' notes on statistical issues in design and analysis of thorough QTc studies.
Tsong Y; Zhang J
J Biopharm Stat; 2008; 18(3):405-7. PubMed ID: 18470752
[No Abstract] [Full Text] [Related]
34. A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.
Stylianou A; Roger J; Stephens K
J Biopharm Stat; 2008; 18(3):502-16. PubMed ID: 18470759
[TBL] [Abstract][Full Text] [Related]
35. Statistical analysis methods for QT/QTc prolongation.
Ma H; Smith B; Dmitrienko A
J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
[TBL] [Abstract][Full Text] [Related]
36. On the designs of thorough QT/QTc clinical trials.
Tsong Y
J Biopharm Stat; 2013; 23(1):43-56. PubMed ID: 23331220
[TBL] [Abstract][Full Text] [Related]
37. Sample size re-estimation for adaptive sequential design in clinical trials.
Gao P; Ware JH; Mehta C
J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
[TBL] [Abstract][Full Text] [Related]
38. QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysis.
Agin MA; Aronstein WS; Ferber G; Geraldes MC; Locke C; Sager P
J Biopharm Stat; 2008; 18(3):408-26. PubMed ID: 18470753
[TBL] [Abstract][Full Text] [Related]
39. The reassessment of trial perspectives from interim data--a critical view.
Bauer P; Koenig F
Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
[TBL] [Abstract][Full Text] [Related]
40. Sample size calculation for cluster randomized cross-over trials.
Giraudeau B; Ravaud P; Donner A
Stat Med; 2008 Nov; 27(27):5578-85. PubMed ID: 18646266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]